Stay informed with the latest litigation news. Explore now

Molnia patent opposition analysis

The comprehensive analysis of Molnia opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Molnia

Patent NumberTitleApplicantOpposition DateOpposition Company
Nutritional ProductUCL BUSINESSJul 29, 2025MOLNIA
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTFeb 26, 2025RATIOPHARM
Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRSJan 15, 2025DORRIES
Methods For Treating Skin Infection By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSNov 13, 2024DORRIES
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGYNov 7, 2024DORRIES
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementALEXION PHARMACEUTICALSOct 28, 2024AMGEN TECHNOLOGY IRELAND UNLIMITED
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerTRON TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITTSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITT MAINZ GEMEINNTZIGEOct 10, 2024DR H ULRICH DORRIES
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYOct 1, 2024DR H ULRICH DORRIES
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYAug 1, 2024DR H ULRICH DORRIES
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJul 3, 2024DR H ULRICH DORRIES